Additional file 1: Table S1. of A phase I dose-escalation study of PEP02 (irinotecan liposome injection) in combination with 5-fluorouracil and leucovorin in advanced solid tumors

  • Nai Jung Chiang (Contributor)
  • Tsu-Yi Chao (Contributor)
  • Ruey Kuen Hsieh (Contributor)
  • Cheng Hsu Wang (Contributor)
  • Yi Wen Wang (Contributor)
  • C. Yeh (Contributor)
  • Li Tzong Chen (Contributor)

Dataset

Description

Tumor type, dose level, DLT, best response and single nucleotide polymorphisms of UGT1A1*28 and UGT1A1*6. (DOCX 18Â kb)
Date made availableNov 21 2016
PublisherUnknown Publisher

Cite this